Livac Pty Ltd was awarded an Australian Federal Government (Commercialisation Australia) Grant in early 2013, which contributed to development of the LiVac retractor to surgical standards and the conduct of a successful First in Human Trial.

The LiVac Retractor was used in a mix of Reduced Port (3 port) Cholecystectomies, gastric banding and fundoplication, as well as single port cholecystectomies.

There were no Device-Related Adverse Events, and every patient had a liver ultrasound the day after surgery, which was normal.